Physician profile
Amit Vyas
NPI 1861591356
$1,463.28
in general payments reported to CMS, 2019-2025
16 companies · $332 in 2025
The $332 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $174 · 2021: $204 · 2022: $274 · 2023: $88.95 · 2024: $95.97 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $689.93 | 2019-2023 | Lifevest |
| Lilly USA, LLC | $109.57 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.46 | 2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $71.95 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $68.38 | 2022-2025 | Farxiga, Wainua |
| Merck Sharp & Dohme LLC | $65.34 | 2022-2025 | Verquvo, Capvaxive |
| Pfizer INC. | $57.36 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.20 | 2025 | |
| Kestra Medical Technology Services, INC. | $46.58 | 2024-2025 | Assure Wcd |
| Alkermes, INC. | $40.10 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.53 | 2022 | |
| Abbott Laboratories | $29.48 | 2025 | Cardiomems |
| Abiomed | $29.23 | 2024 | Impella |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $26.24 | 2022 | |
| Corcept Therapeutics | $19.46 | 2025 | Korlym |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $18.47 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Vyas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.